Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jun 19, 2024 1:47pm

82 Views

Post# 36096311

Interesting Hugh MacNaught likes this...post on GEHC

Hugh MacNaught likes this

I am excited to share that I have accepted the role of president and CEO of Imaging with GE HealthCare! This is an incredible opportunity to lead a global business with more than $8.9 billion in annual revenue on the front lines of innovation for diagnostic and therapeutic imaging through technologies like MRI, CT, Molecular Imaging, X-ray, Mammography & Enterprise Solutions. I look forward to tackling new challenges and to helping drive continued success in this important segment that is vital to delivering efficient, precise, personalized care.

I also want to extend my deepest appreciation to my talented colleagues in Ultrasound who I had the pleasure to work with over the last 13 years and reach and sustain a strong industry leadership position. I am passing the baton and extend a very warm welcome to Philip Rackliffe who will take this journey further as the new president and CEO of Ultrasound and Image Guided Therapy (IGT). I have had the pleasure of working with Phil for two years and he brings extensive expertise and entrepreneurial leadership style to Ultrasound. He is joining a fantastic team – the future is bright for Ultrasound & IGT.

A special thanks goes out to Jan Makela for his exceptional Imaging leadership over the past several years. I am fortunate to continue the work of such a unique leader as Jan, who has been nothing but supportive and helpful as I take this next step with Imaging.

Here’s to new beginnings!